Literature DB >> 33562271

Oxidative Stress and Low-Grade Inflammation in Polycystic Ovary Syndrome: Controversies and New Insights.

Antonio Mancini1,2, Carmine Bruno1,2, Edoardo Vergani1,2, Claudia d'Abate1,2, Elena Giacchi3, Andrea Silvestrini2,4.   

Abstract

The pathophysiology of Polycystic Ovary Syndrome (PCOS) is quite complex and different mechanisms could contribute to hyperandrogenism and anovulation, which are the main features of the syndrome. Obesity and insulin-resistance are claimed as the principal factors contributing to the clinical presentation; in normal weight PCOS either, increased visceral adipose tissue has been described. However, their role is still debated, as debated are the biochemical markers linked to obesity per se. Oxidative stress (OS) and low-grade inflammation (LGI) have recently been a matter of researcher attention; they can influence each other in a reciprocal vicious cycle. In this review, we summarize the main mechanism of radical generation and the link with LGI. Furthermore, we discuss papers in favor or against the role of obesity as the first pathogenetic factor, and show how OS itself, on the contrary, can induce obesity and insulin resistance; in particular, the role of GH-IGF-1 axis is highlighted. Finally, the possible consequences on vitamin D synthesis and activation on the immune system are briefly discussed. This review intends to underline the key role of oxidative stress and low-grade inflammation in the physiopathology of PCOS, they can cause or worsen obesity, insulin-resistance, vitamin D deficiency, and immune dyscrasia, suggesting an inverse interaction to what is usually considered.

Entities:  

Keywords:  antioxidants; hyperandrogenism; insulin-resistance; obesity

Mesh:

Year:  2021        PMID: 33562271      PMCID: PMC7915804          DOI: 10.3390/ijms22041667

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  166 in total

Review 1.  Hormones and antioxidant systems: role of pituitary and pituitary-dependent axes.

Authors:  A Mancini; R Festa; V Di Donna; E Leone; G P Littarru; A Silvestrini; E Meucci; A Pontecorvi
Journal:  J Endocrinol Invest       Date:  2010-06       Impact factor: 4.256

2.  Control of oxidative stress and metabolic homeostasis by the suppression of postprandial hyperglycemia.

Authors:  Eiji Takeda; Hidekazu Arai; Hironori Yamamoto; Hisami Okumura; Yutaka Taketani
Journal:  J Med Invest       Date:  2005-11

3.  Circulating lipocalin 2 is associated with body fat distribution at baseline but is not an independent predictor of insulin resistance: the prospective Cyprus Metabolism Study.

Authors:  Xiaowen Liu; Ole-Petter R Hamnvik; Michael Petrou; Huizhi Gong; John P Chamberland; Costas A Christophi; Stefanos N Kales; David C Christiani; Christos S Mantzoros
Journal:  Eur J Endocrinol       Date:  2011-09-01       Impact factor: 6.664

4.  Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5.

Authors:  Matam Vijay-Kumar; Jesse D Aitken; Frederic A Carvalho; Tyler C Cullender; Simon Mwangi; Shanthi Srinivasan; Shanthi V Sitaraman; Rob Knight; Ruth E Ley; Andrew T Gewirtz
Journal:  Science       Date:  2010-03-04       Impact factor: 47.728

5.  Obesity, and not insulin resistance, is the major determinant of serum inflammatory cardiovascular risk markers in pre-menopausal women.

Authors:  H F Escobar-Morreale; G Villuendas; J I Botella-Carretero; J Sancho; J L San Millán
Journal:  Diabetologia       Date:  2003-05-09       Impact factor: 10.122

6.  Regulation of transcription factor mRNA accumulation during 3T3-L1 preadipocyte differentiation by tumour necrosis factor-alpha.

Authors:  J M Stephens; M D Butts; P H Pekala
Journal:  J Mol Endocrinol       Date:  1992-08       Impact factor: 5.098

7.  Tlr-4 deficiency selectively protects against obesity induced by diets high in saturated fat.

Authors:  Jeremy E Davis; Nicholas K Gabler; Jennifer Walker-Daniels; Michael E Spurlock
Journal:  Obesity (Silver Spring)       Date:  2008-04-10       Impact factor: 5.002

8.  T Helper Cells Profile and CD4+CD25+Foxp3+Regulatory T Cells in Polycystic Ovary Syndrome.

Authors:  Fatemeh Nasri; Mehrnoosh Doroudchi; Bahia Namavar Jahromi; Behrouz Gharesi-Fard
Journal:  Iran J Immunol       Date:  2018-09       Impact factor: 1.603

9.  The effect of bariatric surgery on inflammatory markers in women with polycystic ovarian syndrome.

Authors:  Firass Abiad; Dalia Khalife; Bassem Safadi; Ramzi Alami; Johnny Awwad; Fatin Khalifeh; Ghina Ghazeeri
Journal:  Diabetes Metab Syndr       Date:  2018-06-22

10.  β-carotene oxygenase 2 deficiency-triggered mitochondrial oxidative stress promotes low-grade inflammation and metabolic dysfunction.

Authors:  Lei Wu; Peiran Lu; Xin Guo; Kun Song; Yi Lyu; James Bothwell; Jinglong Wu; Olivia Hawkins; Stephen L Clarke; Edralin A Lucas; Brenda J Smith; Winyoo Chowanadisai; Steve D Hartson; Jerry W Ritchey; Weiqun Wang; Denis M Medeiros; Shitao Li; Dingbo Lin
Journal:  Free Radic Biol Med       Date:  2021-01-13       Impact factor: 7.376

View more
  15 in total

Review 1.  Mast Cell Activation Syndrome in COVID-19 and Female Reproductive Function: Theoretical Background vs. Accumulating Clinical Evidence.

Authors:  Dariusz Szukiewicz; Piotr Wojdasiewicz; Mateusz Watroba; Grzegorz Szewczyk
Journal:  J Immunol Res       Date:  2022-06-22       Impact factor: 4.493

2.  Effects of Kelulut Honey on Oestrus Cycle Regulation and Histomorphological Changes in Letrozole-Induced Polycystic Ovary Syndrome Rats: A Preliminary Study.

Authors:  Datu Agasi Mohd Kamal; Siti Fatimah Ibrahim; Azizah Ugusman; Mohd Helmy Mokhtar
Journal:  Life (Basel)       Date:  2022-06-14

3.  Nanocurcumin Modulates miR-223-3p and NF-κB Levels in the Pancreas of Rat Model of Polycystic Ovary Syndrome to Attenuate Autophagy Flare, Insulin Resistance and Improve ß Cell Mass.

Authors:  Nermeen Z Abuelezz; Marwa E Shabana; Laila Rashed; George Nb Morcos
Journal:  J Exp Pharmacol       Date:  2021-08-26

Review 4.  Clinical and Biochemical Potential of Antioxidants in Treating Polycystic Ovary Syndrome.

Authors:  Xiangyi Cheng; Bing He
Journal:  Int J Womens Health       Date:  2022-04-01

5.  Oxidative Stress in Metabolic and Endocrine Diseases: Basic and Translational Aspects.

Authors:  Antonio Mancini; Andrea Silvestrini
Journal:  Int J Mol Sci       Date:  2022-04-14       Impact factor: 5.923

6.  Effects of Bu Shen Hua Zhuo formula on the LPS/TLR4 pathway and gut microbiota in rats with letrozole-induced polycystic ovary syndrome.

Authors:  Yang Wang; Hui Xiao; Yanxia Liu; Qing Tong; Yanyan Yu; Bing Qi; Xiaoling Bu; Tianyuan Pan; Yu Xing
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-09       Impact factor: 6.055

7.  Differential expression of microRNA in the serum of patients with polycystic ovary syndrome with insulin resistance.

Authors:  Yan Huo; Shuqing Ji; Hua Yang; Weifan Wu; Lijing Yu; Yajing Ren; Fang Wang
Journal:  Ann Transl Med       Date:  2022-07

8.  Relation between Inflammation, Oxidative Stress, and Macronutrient Intakes in Normal and Excessive Body Weight Adolescent Girls with Clinical Features of Polycystic Ovary Syndrome.

Authors:  Małgorzata Mizgier; Grażyna Jarząbek-Bielecka; Natalia Wendland; Elżbieta Jodłowska-Siewert; Marcin Nowicki; Alicja Brożek; Witold Kędzia; Dorota Formanowicz; Justyna Opydo-Szymaczek
Journal:  Nutrients       Date:  2021-03-10       Impact factor: 5.717

Review 9.  Polycystic Ovary Syndrome in Insulin-Resistant Adolescents with Obesity: The Role of Nutrition Therapy and Food Supplements as a Strategy to Protect Fertility.

Authors:  Valeria Calcaterra; Elvira Verduci; Hellas Cena; Vittoria Carlotta Magenes; Carolina Federica Todisco; Elisavietta Tenuta; Cristina Gregorio; Rachele De Giuseppe; Alessandra Bosetti; Elisabetta Di Profio; Gianvincenzo Zuccotti
Journal:  Nutrients       Date:  2021-05-28       Impact factor: 5.717

Review 10.  Polycystic Ovary Syndrome: A Comprehensive Review of Pathogenesis, Management, and Drug Repurposing.

Authors:  Hosna Mohammad Sadeghi; Ida Adeli; Daniela Calina; Anca Oana Docea; Taraneh Mousavi; Marzieh Daniali; Shekoufeh Nikfar; Aristidis Tsatsakis; Mohammad Abdollahi
Journal:  Int J Mol Sci       Date:  2022-01-06       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.